Ambrose Kristen

Ambrose Kristen, SVP & Chief Accounting Officer, has filed 5 insider trading reports covering 1 company. Total disclosed trading volume is $2.1M. Sales ($914.6K) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves VERTEX PHARMACEUTICALS INC / MA (VRTX). All transactions sourced from SEC Form 4 filings.